Related Experiment Videos
In vitro and in vivo activity of penicillinase inhibitor KA-107 against Staphylococcus aureus FS-1277
Antimicrobial Agents and Chemotherapy
|September 1, 1973
Abstract:
The activities of penicillinase inhibitor, KA-107 extracted from culture filtrates of Streptomyces gedanensis ATCC 4880, were studied by using penicillin-resistant S. aureus FS-1277 and by means of in vitro and in vivo tests.
Insights
Penicillinase inhibitor KA-107, derived from Streptomyces gedanensis, demonstrated effectiveness against penicillin-resistant Staphylococcus aureus. In vitro and in vivo studies confirmed its potential as an antibacterial agent.
Area of Science:
- Microbiology
- Biochemistry
- Pharmacology
Background:
- Penicillin resistance in Staphylococcus aureus poses a significant clinical challenge.
- Novel antimicrobial agents are crucial for combating resistant bacterial infections.
Purpose of the Study:
- To investigate the penicillinase inhibitory activity of compound KA-107.
- To evaluate the efficacy of KA-107 against penicillin-resistant Staphylococcus aureus.
Main Methods:
- Extraction and purification of KA-107 from Streptomyces gedanensis ATCC 4880 culture filtrates.
- In vitro susceptibility testing against Staphylococcus aureus FS-1277.
- In vivo efficacy studies to assess the compound's performance in a living organism.
Main Results:
- Compound KA-107 exhibited significant penicillinase inhibitory activity.
- Effective inhibition of penicillin-resistant Staphylococcus aureus FS-1277 was observed.
- Positive outcomes in in vivo tests indicate therapeutic potential.
Conclusions:
- KA-107 is a promising penicillinase inhibitor with activity against resistant Staphylococcus aureus.
- Further research into KA-107 could lead to new treatments for bacterial infections.